Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 23(4): 1278-91, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12556488

ABSTRACT

Regulation of the apoptotic threshold is of great importance in the homeostasis of both differentiating and fully developed organ systems. Triggering differentiation has been employed as a strategy to inhibit cell proliferation and accelerate apoptosis in malignant cells, in which the apoptotic threshold is often characteristically elevated. To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied death receptor responses during erythroid differentiation of K562 erythroleukemia cells, which normally are highly resistant to tumor necrosis factor (TNF) alpha-, FasL-, and TRAIL-induced apoptosis. However, upon hemin-mediated erythroid differentiation, K562 cells specifically lost their resistance to TNF-related apoptosis-inducing ligand (TRAIL), which efficiently killed the differentiating cells independently of mitochondrial apoptotic signaling. Concomitantly with the increased sensitivity, the expression of both c-FLIP splicing variants, c-FLIP(L) and c-FLIP(S), was downregulated, resulting in an altered caspase 8 recruitment and cleavage in the death-inducing signaling complex (DISC). Stable overexpression of both c-FLIP(L) and c-FLIP(S) rescued the cells from TRAIL-mediated apoptosis with isoform-specific effects on DISC-recruited caspase 8. Our results show that c-FLIP(L) and c-FLIP(S) potently control TRAIL responses, both by distinct regulatory features, and further imply that the differentiation state of malignant cells determines their sensitivity to death receptor signals.


Subject(s)
Apoptosis/physiology , Carrier Proteins/metabolism , Cell Differentiation/physiology , Intracellular Signaling Peptides and Proteins , K562 Cells/pathology , Membrane Glycoproteins/metabolism , Tumor Necrosis Factor-alpha/metabolism , Alternative Splicing , Apoptosis Regulatory Proteins , CASP8 and FADD-Like Apoptosis Regulating Protein , Carrier Proteins/genetics , Caspase 8 , Caspase 9 , Caspases/metabolism , Cell Differentiation/drug effects , Cytochrome c Group/metabolism , Death Domain Receptor Signaling Adaptor Proteins , Down-Regulation , HL-60 Cells/metabolism , HL-60 Cells/pathology , Hemin/pharmacology , Humans , Intracellular Membranes , K562 Cells/metabolism , Membrane Glycoproteins/pharmacology , Membrane Potentials/drug effects , Mitochondria/metabolism , Protein Isoforms , Proto-Oncogene Proteins c-bcl-2/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction , TNF-Related Apoptosis-Inducing Ligand , Tumor Necrosis Factor-alpha/pharmacology , bcl-X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...